Singapore In vitro toxicity testing market size is expected to witness
notable growth in the coming years due to the advantages offered by IVTT, such
as enhanced accuracy, efficiency, and reliability as compared to other
traditional methods. Furthermore, increase in applications of IVTT in food and
chemical industries, are the in vitro toxicity testing market trends. Moreover,
stringent government regulations aimed at reducing the cruelty while performing
experiment on animals, increase illicit drug abuse, and enhanced efficiency of IVTT
in diagnosis are the major driving factors for the growth of the market. The
impact of these drivers is expected to increase significantly due to increase
in awareness about the benefits of IVTT. Some of the restraints associated with
the IVTT market are decrease adoption rate of IVTT and incapability of IVTT to
detect toxicities due to autoimmunity & immunostimulation. With the
advancement in the technology, the challenges of IVTT are expected to reduce in
the coming years. A rise in need for testing in various industries such as
pharmaceuticals, food, and others, which drives the growth of the in vitro
toxicology testing market.
The in vitro toxicology testing market is segmented into
type, technology, end users, and region. By type, the market is categorized
into absorption, toxic substances, and dose. Currently, the absorption segment
dominates the global in vitro toxicity testing market growth.
On the basis of end users, the Singapore market is categorized into
pharmaceuticals, cosmetics & household products, chemicals industry, and
food industry. The cosmetics and households products segment is dominant among
end users, followed by the pharmaceutical industry.
On the basis of technology, the Singapore in vitro toxicity testing
market is segmented into cell culture technologies, high throughput
technologies, and toxicogenomics. The cell culture technologies have the
highest in vitro toxicity testing market share in 2020.
On the basis of region, the Singapore in vitro toxicity testing market
is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North
America is the highest revenue growth, followed by Europe. LAMEA is predicted
to grow faster than Asia-Pacific with a CAGR of 16.7% during the forecast
period. The LAMEA segment is expected to dominate the in vitro toxicity testing
market.
The key players operating in this Singapore market include, Acacia
Pharma Group Plc., AstraZeneca Plc, GlaxoSmithKline Plc, Helsinn Holdings S.A.,
Heron Therapeutics Inc., Inc., General Electric Company, EISAI Pharmaceutical
Pvt Ltd., Catalent, Inc., Laboratory Corporation of America Holdings., and
Thermo Fisher Scientific, Inc.
𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱
𝐑𝐞𝐩𝐨𝐫𝐭
https://www.alliedmarketresearch.com/in-vitro-toxicity-testing-market
0 Comments